/

Società

Cl

Non verificato

Cleerly

Di cosa scriviamo

IndustriaMedicina - VarieSaluteScienzaSoftware

17 comunicati stampa

Guarda tutti i comunicati

26/11/2025

Cleerly Unveils PowerScribe Integration and Lesion-Level Reporting at RSNA 2025

Fonte

Emittente

1.00

0

10/11/2025

AHA 2025 Late-Breaking Science: Cleerly’s AI Atherosclerosis Quantification Outperforms Traditional Risk Scoring

Fonte

Emittente

1.00

0

27/10/2025

TCT 2025 Late-Breaking Science: Quantitative Assessment of Non-Calcified Plaque Volume Drives Risk for Myocardial Infarction and Death

Fonte

Emittente

1.00

0

30/09/2025

UnitedHealthcare and Cigna Coverage for Cleerly LABS Advanced Plaque Analysis Begins October 1st

Fonte

Emittente

1.00

0

24/09/2025

Cigna Approves Coverage for Cleerly's AI Cardiovascular Imaging Technology

Fonte

Emittente

1.00

0

03/09/2025

Cleerly Demonstrates Significant Cardiovascular Risk Prediction in Late-Breaking Clinical Science at European Society of Cardiology Congress 2025

Fonte

Emittente

1.00

0

09/07/2025

Cleerly to Showcase New AI-QCT Research at SCCT2025 Annual Meeting

Fonte

Emittente

1.00

0

01/07/2025

Cleerly Announces Key Leadership Promotions: Dr. Udo Hoffmann Named Chief Medical, Scientific and AI Officer; Amit Relia Promoted to Chief Regulatory Officer

Fonte

Emittente

1.00

0

06/05/2025

AI Meets Value-Based Care: Cleerly and Cardiac Care Alliance Join Forces to Revolutionize Heart Disease Detection

Fonte

Emittente

1.00

0

31/03/2025

Cleerly Unveils Groundbreaking Late-Breaking Clinical Trial Results Demonstrating AI-QCT’s Predictive Power for Women’s Cardiovascular Risk at ACC.25

Fonte

Emittente

1.00

0

Seguaci

0

Compatibilità

0